home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Key Blind Mice

 
  September, 9 2003 8:08
your information resource in human molecular genetics
 
     
Visually impaired mice are shedding light on how cataracts are formed. Research in Nature (Vol. 424, No. 6952, dated 28 August 2003, pp. 1071-1074) highlights the importance of a DNA-degrading enzyme that helps developing lenses to remain clear.

The lens is made up of clear fibre cells. As they form, internal structures, such as the nucleus and power-boosting mitochondria, are broken down to prevent the lens from clouding up. Shigekazu Nagata and colleagues have discovered an enzyme, known as DLAD, that catalyses this degradation. The protein is found in normal mouse lens cells, they report. Mice lacking the enzyme are unable to degrade fibre cell DNA, and they develop cataracts.

DLAD is also found in human lens cells, so some cataract patients may carry a deficiency in the DLAD gene, the team speculates. The researchers also hope that the visually impaired mice will provide a useful animal model with which to study human cataract development.

CONTACT:

Shigekazu Nagata
Osaka University Medical School, Japan
Tel: +81 6 6879 3310
E-mail: nagata@genetic.med.osaka-u.ac.jp

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.